A Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol®) in Pediatric Subjects With Euvolemic or Hypervolemic Hyponatremia

PHASE3TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

Hyponatremia

Interventions

DRUG

Conivaptan hydrochloride

Intravenous

DRUG

Placebo

Intravenous

Trial Locations (3)

Children's Hospital of New York - Presbyterian, New York

Fundación Cardioinfantil - Instituto Cardiológico, Bogotá

Fundación Valle del Lili, Cali, Valle